GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Cash Flow from Financing

Ascendis Health (JSE:ASC) Cash Flow from Financing : R-451 Mil (TTM As of Jun. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Jun. 2023, Ascendis Health paid R0 Mil more to buy back shares than it received from issuing new shares. It spent R38 Mil paying down its debt. It paid R0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received R0 Mil from paying cash dividends to shareholders. It received R0 Mil on other financial activities. In all, Ascendis Health spent R38 Mil on financial activities for the six months ended in Jun. 2023.


Ascendis Health Cash Flow from Financing Historical Data

The historical data trend for Ascendis Health's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Cash Flow from Financing Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.45 -364.68 -266.88 -1,273.43 -450.53

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -177.57 -1,240.36 -33.07 -403.12 -47.41

Ascendis Health Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Ascendis Health's Cash from Financing for the fiscal year that ended in Jun. 2023 is calculated as:

Ascendis Health's Cash from Financing for the quarter that ended in Jun. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R-451 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascendis Health  (JSE:ASC) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Ascendis Health's issuance of stock for the six months ended in Jun. 2023 was R0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Ascendis Health's repurchase of stock for the six months ended in Jun. 2023 was R0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Ascendis Health's net issuance of debt for the six months ended in Jun. 2023 was R-38 Mil. Ascendis Health spent R38 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Ascendis Health's net issuance of preferred for the six months ended in Jun. 2023 was R0 Mil. Ascendis Health paid R0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Ascendis Health's cash flow for dividends for the six months ended in Jun. 2023 was R0 Mil. Ascendis Health received R0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Ascendis Health's other financing for the six months ended in Jun. 2023 was R0 Mil. Ascendis Health received R0 Mil on other financial activities.


Ascendis Health Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Health (JSE:ASC) Business Description

Traded in Other Exchanges
N/A
Address
1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.